Table A3: Data from Studies Included in Review.
| Author, Year | Country | Study Design | Sample Size | Outcomes |
|---|---|---|---|---|
| Beiki et al, 2005 (31) | Iran | Cross-sectional | 76 patients with dyspepsia | TP = 40, FP = 1, FN = 0, TN = 35 |
| Bilal et al, 2007 (32) | Pakistan | Cross-sectional | 90 symptomatic patients | TP = 62, FP = 0, FN = 0, TN = 28 |
| Bruden et al, 2011 (16) | USA | Cross-sectional | 280 patients undergoing endoscopy | TP = 139, FP = 16, FN = 10, TN = 115 |
| Calvet et al, 2009 (33) | Spain | Cross-sectional | 199 patients with dyspepsia | TP = 117, FP = 32, FN = 1, TN = 49 |
| Chen et al, 2003 (34) | Taiwan | Cross-sectional | 554 patients undergoing endoscopy | TP = 365, FP = 24, FN = 4, TN = 161 |
| Gatta et al, 2003 (22) | Italy | Cross-sectional | 200 patients with dyspepsia | TP = 113, FP = 0, FN = 0, TN = 87 |
| 109 post-treatment patients | TP = 23, FP = 0, FN = 0, TN = 86 | |||
| Gisbert et al, 2003 (35) | Spain | Cross-sectional | 36 patients with dyspepsia | TP = 25, FP = 0, FN = 1, TN = 10 |
| Gomollon et al, 2003 (17) | Spain | Cross-sectional | 194 patients with dyspepsia | TP = 139, FP = 0, FN = 1, TN = 54 |
| Kato et al, 2004 (36) | Japan | Cross-sectional | 505 patients undergoing endoscopy | TP = 252, FP = 5, FN = 6, TN = 242 |
| Kazemi et al, 2011 (18) | Iran | Cross-sectional | 94 patients with dyspepsia | TP = 33, FP = 15, FN = 4, TN = 42 |
| Kuo et al, 2005 (37) | Taiwan | Cross-sectional | 317 patients with dyspepsia | TP = 211, FP = 8, FN = 19, TN = 79 |
| Leodolter et al, 2003 (19) | Europe | Cross-sectional | 415 patients with dyspepsia | TP = 198, FP = 14, FN = 15, TN = 188 |
| Manes et al, 2005 (23) | Italy | Cross-sectional | 325 gastroenterology referralsa | TP = 93, FP = 1, FN = 1, TN = 230 |
| Ohara et al, 2004 (38) | Japan | Cross-sectional | 251 patients undergoing endoscopy | TP = 125, FP = 3, FN = 3, TN = 120 |
| Peng et al, 2005 (39) | Taiwan | Cross-sectional | 50 patients undergoing endoscopy | TP = 18, FP = 0, FN = 0, TN = 32 |
| Peng et al, 2009 (20) | Taiwan | Cross-sectional | 100 patients undergoing endoscopy | TP = 53, FP = 7 FN = 0, TN = 40 |
| Reynders et al, 2012 (21) | Belgium | Cross-sectional | 117 patients with dyspepsia | TP = 77, FP = 3, FN = 5, TN = 32 |
| Urita et al, 2004 (40) | Japan | Cross-sectional | 127 patients undergoing endoscopy | TP = 41, FP = 8, FN = 1, TN = 77 |
| Wong et al, 2003 (41) | Hong Kong | Cross-sectional | 200 patients with dyspepsiab | TP = 99, FP = 2, FN = 0, TN = 99 |
| Wu et al, 2006 (42) | Taiwan | Cross-sectional | 254 patients with dyspepsiac | TP = 105, FP = 18, FN = 4, TN = 127 |
| Cuddihy et al, 2005 (24) | USA | Randomized controlled trial | 43 patients randomized to 1 of 4 different management strategies | Resolution of symptoms, medication use, and number of visits were similar across all arms; 13C UBT group had higher dyspepsia-specific, quality of life scores than other arms |
Abbreviations: FP, false–positive results; FN, false–negative results; TN, true–negative results; TP, true–positive results.
a
Study evaluated accuracy in post-treatment patients only.
b
Study included 50 post-treatment patients.
c
Study included 67 post-treatment patients.